The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Market Cap
576 billion
PE Ratio
83.33 x
Beta (volatility)
0.33
Earnings Per Share
6.48
About
ISIN : US5324571083
It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro...
Price
Performance Comparison
| Eli Lilly and Company | |
|---|---|
| 1 year return | - |
| 5 years return | - |
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 0.00 | 56 % | 0.00 |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| 20.18 | 61.16 | 0.00 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
Uninter. Dividend
-
Frequency
0x / year
Dividends in 2024
Dividends in 2023
February
Dividends in 2023
February
Forward Annual Amount
CHF 0.00
Ex-dividend
2/14/2023
Number of Outstanding Shares
Financials
Year-over-Year growth
Profitability
Health
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2025 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.